RightFit Trial Directory

Lupus clinical trials in Houston, TX

15 recruiting lupus studies with a site in Houston, TX.

All trials in Houston, TX · All Lupus trials

RecruitingPhase 1NCT07607964

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Sponsor: AbbVie

Houston, TX · Red Oak, TX · +10 more sites

RecruitingPhase 3NCT06617325

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Sponsor: UCB Biopharma SRL

Bellaire, TX · El Paso, TX · Fort Worth, TX · +60 more sites

RecruitingPhase 2NCT07409181

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Sponsor: Boehringer Ingelheim

Amarillo, TX · Colleyville, TX · Euless, TX · +27 more sites

RecruitingPhase 1 / Phase 2NCT06121297

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Sponsor: Cabaletta Bio

Houston, TX · +20 more sites

RecruitingPhase 1 / Phase 2NCT06434363

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 1NCT03816345

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Sponsor: National Cancer Institute (NCI)

Dallas, TX · Fort Worth, TX · +48 more sites

RecruitingPhase 2NCT06570798

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

Sponsor: Amgen

Houston, TX · +17 more sites

RecruitingPhase 3NCT05835310

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Sponsor: AstraZeneca

El Paso, TX · Houston, TX · +20 more sites

RecruitingPhase 3NCT07430306

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Sponsor: AstraZeneca

Austin, TX · Baytown, TX · Colleyville, TX · +28 more sites

RecruitingPhase 2NCT05538208

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

Sponsor: Children's Hospital Medical Center, Cincinnati

Houston, TX · +18 more sites

RecruitingPhase 1NCT06975787

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

Sponsor: Regeneron Pharmaceuticals

Houston, TX · +2 more sites

RecruitingPhase 4NCT07611214

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

Sponsor: Aurinia Pharmaceuticals Inc.

Bellaire, TX · Dallas, TX · El Paso, TX · +24 more sites

RecruitingPhase 3NCT07201129

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Sponsor: Viatris Innovation GmbH

Bellaire, TX · El Paso, TX · Houston, TX · +11 more sites

RecruitingPhase 1 / Phase 2NCT06557265

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Sponsor: Nkarta, Inc.

Dallas, TX · Houston, TX · +15 more sites

RecruitingPhase not listedNCT04751396

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Sponsor: M.D. Anderson Cancer Center

Houston, TX

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.